MedPath

Acne Treatment with topical gel azithromycin 2%

Not Applicable
Conditions
Acne Vulgaris.
Acne vulgaris
Registration Number
IRCT2014031216970N1
Lead Sponsor
VICE CHANCELLOR FOR RESEARCH OF ISFAHAN UNIVERSITY OF MEDICAL SCIENCES
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
40
Inclusion Criteria

patients with mild and moderate FDA acne grading system scale , aged 12 to 45 years, both sexes, written informed consent for participation in the study , not receiving topical antibiotics within two weeks and systemic medications that are effective in acne within a month prior to the study, no history of hypersensitivity to any of the studies medications. Exclusion criteria: pregnancy or lactation, medical allergy or side effects, non- cooperation or lack of satisfactory treatment, the need for systemic medication during the study or concomitant use of drugs affecting acne

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Severity of Acne. Timepoint: Beginning of the study design, 4th and 8th weeks of the treatment and 2 months after treatment. Method of measurement: Total count of lesions= TLC and acne severity index = ASI.;Patient satisfaction. Timepoint: 4th and 8th weeks of treatment and 2 months after treatment. Method of measurement: Scale of 10 ratings.
Secondary Outcome Measures
NameTimeMethod
Burning and itching. Timepoint: 4th and 8th weeks of treatment and 2 months after treatment. Method of measurement: A scale of 4 ratings.;Erythema. Timepoint: 4th and 8th weeks of treatment and 2 months after treatment. Method of measurement: A scale of 4 ratings.;Dry. Timepoint: 4th and 8th weeks of treatment and two months after treatment. Method of measurement: A scale of 4 ratings.;Desquamation and peeling. Timepoint: 4th and 8th weeks of treatment and 2 months after treatment. Method of measurement: A scale of 4 ratings.;Recurrence. Timepoint: 2 months after treatment. Method of measurement: index of severity of acne=ASI Total lesion count = TLC.
© Copyright 2025. All Rights Reserved by MedPath